AccessToTreatment.org represents the cooperative effort of
four companies:
Boehringer Ingelheim International GmbH,
Novartis Pharmaceuticals, and
Pfizer. The platform was designed and is administered by
Axios International, specialists of chronic care systems in developing
countries.
Our goal is to enable institutions and their patients in eligible countries to access the medical products provided within this initiative, either as a donation or within the framework of other Axios creative access strategies. Currently there are the following products available: Diflucan, Glivec, and Viramune,and
GARDASIL® (through the GARDASIL®
Access Program). Please refer to Programs for further information.
Our unique advantage is a global network of 450 healthcare institutions in 116 countries (June, 2008). This network gives us large scale intervention capabilities and a repository of comprehensive data and local knowledge. Over 8,000,000 people have received tests or treatment through Axios-managed programs.
We are actively recruiting additional
manufacturers and institutions.
Role of Axios International
Axios International works with
participating healthcare institutions and manufacturers, to ensure the proper
match between products and institutions, analyzing supply and demand, ensuring
the respect of pharmaceutical requirements, and the communication of necessary
data among partners via a web-based network.
Axios assists applicant institutions by engaging in dialogue to
understand the scope of their programs and needs. This includes technical
assistance regarding forecasting, procurement, and logistics.
Axios ensures that healthcare institutions benefiting from the
discounted prices or donations meet the technical standards required for proper
utilization of the drugs and tests.
Axios assists participating manufacturers through the above quality
control assurance and by the sharing of information, experience, and the vision
of Access To Treatment in developing countries.
Role of AHD
Axios Healthcare Development
(AHD)
is a 501(C)(3) Public Charity
based in Cleveland, Ohio, USA
and focused on implementation of
philanthropic healthcare
programs. AHD manages the
GARDASIL® Access Program with
the technical assistance of
Axios International.
